0001214659-22-003108.txt : 20220223 0001214659-22-003108.hdr.sgml : 20220223 20220223180325 ACCESSION NUMBER: 0001214659-22-003108 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20220218 FILED AS OF DATE: 20220223 DATE AS OF CHANGE: 20220223 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: THORBURN JAMES M CENTRAL INDEX KEY: 0001252038 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-38720 FILM NUMBER: 22665400 MAIL ADDRESS: STREET 1: C/O ZILOG INC STREET 2: 532 RACE STREET CITY: SAN JOSE STATE: CA ZIP: 95126 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Twist Bioscience Corp CENTRAL INDEX KEY: 0001581280 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 462058888 STATE OF INCORPORATION: DE FISCAL YEAR END: 0930 BUSINESS ADDRESS: STREET 1: 681 GATEWAY BLVD. CITY: SOUTH SAN FRANCISCO STATE: CA ZIP: 94080 BUSINESS PHONE: 800-719-0671 MAIL ADDRESS: STREET 1: 681 GATEWAY BLVD. CITY: SOUTH SAN FRANCISCO STATE: CA ZIP: 94080 4 1 marketforms-55522.xml PRIMARY DOCUMENT X0306 4 2022-02-18 0001581280 Twist Bioscience Corp TWST 0001252038 THORBURN JAMES M C/O TWIST BIOSCIENCE CORPORATION 681 GATEWAY BLVD. SOUTH SAN FRANCISCO CA 94080 false true false false Chief Financial Officer Common Stock 2022-02-18 4 F false 1025 53.21 D 47925 D Common Stock 2022-02-22 4 M false 1517 26.66 A 49442 D Common Stock 2022-02-22 4 M false 2000 23.33 A 51442 D Common Stock 2022-02-22 4 S false 2461 52.0345 D 48981 D Common Stock 2022-02-22 4 S false 1341 52.8814 D 47640 D Common Stock 2022-02-22 4 S false 640 53.6641 D 47000 D Employee Stock Option (right to buy) 26.66 2022-02-22 4 M false 1517 0 D 2028-11-18 Common Stock 1517 41898 D Employee Stock Option (right to buy) 23.33 2022-02-22 4 M false 2000 0 D 2029-10-23 Common Stock 2000 27748 D Represents shares withheld by the Issuer to satisfy the Reporting Person's tax withholding obligation in connection with the vesting of certain Restricted Stock Units ("RSUs") previously granted to the Reporting Person. Such withholding is exempt from Section 16(b) pursuant to Rule 16b-3(e). The transactions reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the Reporting Person on August 24, 2021. Represents the weighted average sales price per share. The shares sold at prices ranging from $51.44 to $52.42 per share. Full information regarding the number of shares sold at each price shall be provided upon request to the staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer. Represents the weighted average sales price per share. The shares sold at prices ranging from $52.45 to $53.36 per share. Full information regarding the number of shares sold at each price shall be provided upon request to the staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer. Represents the weighted average sales price per share. The shares sold at prices ranging from $53.50 to $54.09 per share. Full information regarding the number of shares sold at each price shall be provided upon request to the staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer. 20% of the shares subject to the option vested and became exercisable on October 31, 2019, and 1/60th of the shares subject to the option vest and become exercisable on each monthly anniversary thereafter, subject to the Reporting Person's continuous service through each vesting date. 25% of the shares subject to the option vested and became exercisable on October 24, 2020, and 1/48th of the shares subject to the option vest and become exercisable on each monthly anniversary thereafter, subject to the Reporting Person's continuous service through each vesting date. /s/ William Solis, as Attorney-in-Fact for James M. Thorburn 2022-02-23